IN8bio(DE:6JH0)
€0.78-0.01 (-1.27%)
DE:6JH0
IN8bio financials statements
€0.78
At close:-0.01 (-1.27%)
IN8bio (6JH0) Income Statement
1 Followers
IN8bio Income Statement
Last quarter (Q3 2026), IN8bio's total revenue was $0.00. In Q3, IN8bio's net income was $-4.59M. See IN8bio’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ -2.50M | $ 0.00 | $ -2.50M | $ 0.00 | $ 0.00 | |
| $ 17.36M | $ 30.44M | $ 27.84M | $ 28.52M | $ 14.65M | |
| Depreciation and Amortization | $ 2.50M | $ 2.65M | $ 2.50M | $ 1.10M | $ 788.00K |
| $ -16.94M | $ -26.94M | $ -27.51M | $ -27.42M | $ -13.87M | |
| $ -19.86M | $ -30.44M | $ -30.34M | $ -28.52M | $ -14.65M | |
| $ 421.00K | $ 0.00 | $ 330.00K | $ 0.00 | $ 0.00 | |
| $ -19.44M | $ -30.44M | $ -30.01M | $ -28.52M | $ -14.65M | |
| $ -19.44M | $ -30.44M | $ -30.01M | $ -28.52M | $ -14.65M | |
| Per Share Metrics | |||||
| Basic EPS | $ -4.44 | $ -17.05 | $ -30.14 | $ -40.81 | $ -23.41 |
| Diluted EPS | $ -4.44 | $ -17.05 | $ -30.14 | $ -40.81 | $ -23.41 |
| Weighted Average Shares Outstanding | 4.37M | 1.78M | 995.50K | 698.93K | 626.04K |
| Weighted Average Shares Outstanding (Diluted) | 4.37M | 1.78M | 995.50K | 698.93K | 626.04K |
Currency in USD
